CC Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in The Chemours Company Securities Lawsuit - Contact SueWallSt
Notice to Pension Funds, Asset Managers, and Fiduciaries: The lawsuit alleges Chemours overstated aftermarket demand for its Opteon refrigerants and reaffirmed 2026 guidance that did not account for sales pulled forward by 2025 distributor stocking. NEW YORK, Oct. 15, 2026 /PRNewswire/ --...
Covered in this story
What has happened since
- Chemours is up 0.5% since this was published, 5 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Chemours
- RBC Capital Markets: $13.4 → $14 by Oct 2027 · Sector Perform via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $CC yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Chemours →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.